Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2003
Limited access trial using amifostine for protection against cisplatin- and three-hour paclitaxel-induced neurotoxicity: a phase II study of the Gynecologic Oncology Group
David H Moore, James Donnelly, William P McGuire, et al.
Gynecologic Oncology
|
October 20, 2006
Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study
Agustin A Garcia, John A Blessing, Kathleen M Darcy, et al.
Gynecologic Oncology
|
February 7, 2012
Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study
Dana M Chase, Helen Q Huang, Lari Wenzel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 19, 2005
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study
Rachelle Lanciano, Alison Calkins, Brian N Bundy, et al.
Gynecologic Oncology
|
February 22, 2005
Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study
Achilles J Fakiris, David H Moore, Shailaja R Reddy, et al.
Gynecologic Oncology
|
November 15, 2011
A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study
David H Moore, Shamshad Ali, Wui-Jin Koh, et al.
The New England Journal of Medicine
|
December 14, 2004
Secondary surgical cytoreduction for advanced ovarian carcinoma
Peter G Rose, Stacy Nerenstone, Mark F Brady, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2004
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study
David H Moore, John A Blessing, Richard P McQuellon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2015
Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study
Krishnansu S Tewari, Michael W Sill, Bradley J Monk, et al.
Oncology (Williston Park, N.Y.)
|
September 17, 2016
ACR Appropriateness Criteria® Adjuvant Management of Early-Stage Endometrial Cancer
Andrew O Wahl, David K Gaffney, Anuja Jhingran, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2003
Limited access trial using amifostine for protection against cisplatin- and three-hour paclitaxel-induced neurotoxicity: a phase II study of the Gynecologic Oncology Group
David H Moore, James Donnelly, William P McGuire, et al.
Gynecologic Oncology
|
October 20, 2006
Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study
Agustin A Garcia, John A Blessing, Kathleen M Darcy, et al.
Gynecologic Oncology
|
February 7, 2012
Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study
Dana M Chase, Helen Q Huang, Lari Wenzel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 19, 2005
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study
Rachelle Lanciano, Alison Calkins, Brian N Bundy, et al.
Gynecologic Oncology
|
February 22, 2005
Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study
Achilles J Fakiris, David H Moore, Shailaja R Reddy, et al.
Gynecologic Oncology
|
November 15, 2011
A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study
David H Moore, Shamshad Ali, Wui-Jin Koh, et al.
The New England Journal of Medicine
|
December 14, 2004
Secondary surgical cytoreduction for advanced ovarian carcinoma
Peter G Rose, Stacy Nerenstone, Mark F Brady, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2004
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study
David H Moore, John A Blessing, Richard P McQuellon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2015
Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study
Krishnansu S Tewari, Michael W Sill, Bradley J Monk, et al.
Oncology (Williston Park, N.Y.)
|
September 17, 2016
ACR Appropriateness Criteria® Adjuvant Management of Early-Stage Endometrial Cancer
Andrew O Wahl, David K Gaffney, Anuja Jhingran, et al.
Page
of 4